Determining Hospital Test Accuracy

Por Boyer, Thomas D.
Publicado em 1979

Management of Portal Vein Thrombosis

Por Boyer, Thomas D.
Publicado em 2008

Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia

Por Habib, Shahid, Boyer, Thomas D.
Publicado em 2012

Hepatology : a textbook of liver diseases /

Por Zakim, David., Boyer, Thomas D.
Publicado em 1996.

Identification of a short form of ubiquitin-specific protease 3 that is a repressor of rat glutathione S-transferase gene expression

Por Whalen, Richard, Liu, Xiangdang, Boyer, Thomas D.
Publicado em 2006

Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes

Por Ranganathan, Perungavar N., Whalen, Richard, Boyer, Thomas D.
Publicado em 2005

Decreased expression levels of rat liver glutathione S-transferase A2 and albumin during the acute phase response are mediated by HNF1 (hepatic nuclear factor 1) and IL6DEX-NP.

Por Whalen, Richard, Voss, Susan H, Boyer, Thomas D
Publicado em 2004

Mechanism of negative regulation of rat glutathione S-transferase A2 by the cytokine interleukin 6.

Por Voss, Susan H, Whalen, Richard, Boyer, Thomas D
Publicado em 2002

Endoscopic ultrasound with biopsy of omental mass for cholangiocarcinoma diagnosis in cirrhosis

Por Rial, Nathaniel S, Gilchrist, Kevin B, Henderson, Jeff T, Bhattacharyya, Achyut K, Boyer, Thomas D, Nadir, Abdul, Cunningham, John T
Publicado em 2011

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics

Por Boyer, Thomas D., Sanyal, Arun J., Garcia-Tsao, Guadalupe, Blei, Andres, Carl, Daniel, Bexon, Alice S., Teuber, Peter
Publicado em 2010

Constitutional telomerase mutations are genetic risk factors for cirrhosis

Por Calado, Rodrigo T., Brudno, Jennifer, Mehta, Paulomi, Kovacs, Joseph J., Wu, Colin, Zago, Marco A., Chanock, Stephen J., Boyer, Thomas D., Young, Neal S.
Publicado em 2011

Impact of Liver Transplantation on the Survival of Patients Treated for Hepatorenal Syndrome Type 1

Por Boyer, Thomas D., Sanyal, Arun J., Garcia-Tsao, Guadalupe, Regenstein, Frederick, Rossaro, Lorenzo, Appenrodt, Beate, Gülberg, Veit, Sigal, Samuel, Bexon, Alice S., Teuber, Peter
Publicado em 2011

Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt

Por Boyer, Thomas D, Henderson, J Michael, Heerey, Adrienne M, Arrigain, Susana, Konig, Vicky, Jason, Connor, Abu-Elmagd, Kareem, Galloway, John, Rikkers, Layton F, Jeffers, Lennox
Publicado em 2007

Differences Between Caucasian, African American, and Hispanic Patients with Primary Biliary Cirrhosis in the United States

Por Peters, Marion G., Di Bisceglie, Adrian M., Kowdley, Kris V., Flye, Nancy L., Luketic, Velimir A., Munoz, Santiago J., Garcia-Tsao, Guadalupe, Boyer, Thomas D., Lake, John R., Bonacini, Maurizio, Combes, Burton
Publicado em 2007

A phase II, randomized, controlled trial of S-adenosylmethionine in reducing serum alpha-fetoprotein (AFP) in patients with hepatitis C cirrhosis and elevated AFP

Por Morgan, Timothy R., Osann, Kathryn, Bottiglieri, Teodoro, Pimstone, Neville, Hoefs, John C., Hu, Ke-Qin, Hassanein, Tarek, Boyer, Thomas D., Kong, Lorene, Chen, Wen-Pin, Richmond, Ellen, Gonzalez, Rachel, Rodriguez, Luz M., Meyskens, Frank L.
Publicado no Cancer Prev Res (Phila) (2015)